|
FY2026
12 months to Mar 28, 2026
|
FY2025
12 months to Mar 29, 2025
|
FY2024
12 months to Mar 30, 2024
|
FY2023
12 months to Apr 1, 2023
|
FY2022
12 months to Apr 2, 2022
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net income (loss) | |||||
| Net income (loss) from discontinued operations, net of tax | |||||
| Net income (loss) from continuing operations | |||||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Share-based compensation expense | |||||
| Impairment of assets | |||||
| Credit losses | |||||
| Deferred income taxes | |||||
| Changes to lease related balances, net | |||||
| Foreign currency losses | |||||
| Other non-cash charges | |||||
| Change in assets and liabilities: | |||||
| Receivables, net | |||||
| Inventories, net | |||||
| Prepaid expenses and other current assets | |||||
| Accounts payable | |||||
| Accrued expenses and other current liabilities | |||||
| Other long-term assets and liabilities | |||||
| Cash Provided by (Used in) Operating Activity, Continuing Operation | |||||
| Cash Provided by (Used in) Operating Activity, Discontinued Operation | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities | |||||
| Capital expenditures | |||||
| Cash paid for business acquisitions, net of cash acquired | |||||
| Settlement of hedges | |||||
| Net cash (used in) provided by investing activities of continuing operations | |||||
| Net cash provided by (used in) investing activities of discontinued operations | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flows from financing activities | |||||
| Debt borrowings | |||||
| Debt repayments | |||||
| Debt issuance costs | |||||
| Repurchase of ordinary shares | |||||
| Settlement of interest rate swaps | |||||
| Exercise of employee share options | |||||
| Other financing activities | |||||
| Net cash used in financing activities of continuing operations | |||||
| Net cash used in financing activities of discontinued operations | |||||
| Net cash used in financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Net decrease in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash of continuing operations, end of period | |||||
| Beginning of period | |||||
| End of period | |||||
| Supplemental disclosures of cash flow information | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes | |||||
| Supplemental disclosure of non-cash investing and financing activities | |||||
| Accrued capital expenditures | |||||
| Summary of cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash of continuing operations, end of period | |||||
| Cash, cash equivalents and restricted cash of discontinued operations, end of period | |||||
Loading...